Circadian Therapeutics
Circadian Therapeutics, founded in 2016 as a spin-out from Oxford University, develops therapeutics to treat diseases associated with disruption of the body clock. The company's research is based on the molecular control of circadian rhythms.
- Project management and IT services
- Therapeutics for circadian rhythm disorders
- Consultancy in development and regulatory support
Locations
Digital Popularity
Social Media
LinkedIn504 Followers
Competitors
PharmaVentures is a premier transaction advisory firm and a leading international company in partnering, M&A deals, and strategic alliances.
Oxford Expression Technologies Ltd is a biotechnology company based in Oxford, England, specialising in baculovirus protein expression.
Allied Pharmacies is a family-owned pharmacy chain established in 2005, partnering with local pharmacists to provide high-quality healthcare services.
Company Details
Circadian Therapeutics is operated by Circadian Therapeutics Limited and is a Active company incorporated on 18 July 2016 with the registered office located in Oxford, Oxfordshire. Circadian Therapeutics Limited was registered 9 years ago.
Status
Active
Size
Micro
Directors
6
Age
9 years old
Employees
2
Turnover
Unreported
Total Assets
£165.98K
Cash in Bank
Unreported
Total Liabilities
-£2.7M
Teams
2
1
1
Founder Circadian Therapeutics • Joined Sep 2017
Board Director
Board Director
Founder Circadian Therapeutics • Joined Sep 2017